Digital imaging offers enhanced image resolution with greater precision, leading to fewer distorted images and allowing for better viewing of samples. The development of whole-slide scanning systems is a major factor that has accelerated the adoption of digital microscopy. These systems offer deep visualization of specimens with 2D and 3D images used in R&D, forensics, quality control, as well as failure analysis. Market players offer various digital microscopy products such as ShuttlePix P-400R (Nikon), Leica DVM6 (Danaher), and Celldiscoverer 7 (Carl Zeiss).
Owing to technological advancements, there has been a shift in the usage patterns of microscopes. Conventional microscopes are gradually losing their popularity to high-end microscopes such as electron microscopes, scanning probe microscopes, and digital microscopes due to their advanced features, higher resolution, and magnification power.
Technological advancements in microscopy include digitization, live-cell imaging, super-resolution, and high-throughput methods. These advancements serve to reduce product and test costs.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=399
[232 Pages Report] The microscopy market is projected to reach USD 8.9 billion in 2026 from USD 6.5 billion in 2020, at a CAGR of 5.6% during the forecast period. Market growth is driven largely by factors such as favorable funding scenario for R&D in microscopy, rising demand for electron microscopes in applied industries (such as semiconductor manufacturing).
The impact of the coronavirus pandemic and the nationwide lockdowns it triggered is visible in various industries, including the microscopy market. The overall growth of various sectors has been heavily impacted, specifically in countries with a high incidence rate of COVID-19, such as India, China, the US, and several European countries (Russia, Italy, and Spain, among others).
While industries such as oil and petroleum, aeronautics, and mining are experiencing a steep fall in revenues, the healthcare, biotechnology, and pharmaceutical industries are optimizing this situation to serve a maximum number of patients and healthcare professionals. The COVID-19 outbreak has disrupted business and economic activities globally. However, it is expected to have a positive impact on the microscopy market for the healthcare industry.
Owing to technological advancements, there has been a shift in the usage patterns of microscopes. Conventional microscopes are gradually losing their popularity to high-end microscopes such as electron microscopes, scanning probe microscopes, and digital microscopes due to their advanced features, higher resolution, and magnification power.
Government funding for R&D in advanced microscopes has increased considerably in these countries. For instance, in February 2017, the Indian government provided funds worth ~USD 45,000 to design and develop multimodal optical microscopes using Fourier optical image processing.
The major companies in the microscopy market include Carl Zeiss (Germany), Danaher Corporation (US), Thermo Fisher Scientific (US), Nikon (Japan), Bruker Corporation (US), Olympus (Japan), Oxford Instruments (UK), JEOL (Japan), and Hitachi High-Technologies (Japan), among others.
